Endocrine changes during treatment of prostate carcinoma (PCA) patients with the LHRH-agonist buserelin (HOE 766)

✍ Scribed by de Jong, F.H.; Schröder, F.H.; Lock, M.T.W.T.; Debruyne, F.M.J.; de Voogt, H.J.; Klijn, J.G.M.

• Book ID: 121964638
• Publisher: Elsevier Science
• Year: 1986
• Weight: 163 KB
• Volume: 22
• Category: Article
• ISSN: 0277-5379
• DOI: 10.1016/0277-5379(86)90191-4